KEGG   DRUG: Dolutegravir and lamivudine
Entry
D11522            Mixture   Drug                                   
Name
Dolutegravir and lamivudine;
Dovato (TN)
Product
DOVATO (ViiV Healthcare Company)
Component
(Dolutegravir sodium [DR:D10113] | Dolutegravir [DR:D10066]), Lamivudine [DR:D00353]
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR25
Product: D11522<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
HIV-1 integrase [KO:K24803]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR25 Lamivudine and dolutegravir
      D11522  Dolutegravir and lamivudine <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Dolutegravir/ Lamivudine
    D11522  Dolutegravir and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11522  Dolutegravir and lamivudine
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D11522  Dolutegravir and lamivudine
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D11522  Dolutegravir and lamivudine
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV integrase inhibitor
    D11522  Dolutegravir and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11522
Other DBs
PubChem: 384585498
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system